Digital droplet PCR (ddPCR) is a recent version of quantitative PCR (QT-PCR), useful for
measuring gene expression, doing clonality assays and detecting hot spot mutations. In …

The introduction of imatinib in 2000 opened the era of tyrosine kinase inhibitors (TKIs) for
CML therapy and has revolutionized the life expectancy of CML patients, which is now quite …

Simple Summary The monitoring of the minimal residual disease (MRD) in Chronic Myeloid
Leukemia is a key element in the management of affected patients because it reflects the …

Background: Droplet digital polymerase chain reaction (ddPCR) is an exact method of
measurement. Objectives: We conducted this study to identify the prognostic factors for …

Chronic myeloid leukemia (CML) has evolved from an invariably fatal disease to a chronic
disorder that can be treated with targeted drugs and allows survival expectations …

Simple Summary The field of artificial intelligence (AI) is quickly becoming recognized for its
potential to significantly improve medicine. AI is still in its infancy when it comes to treating …

The effective and sensitive monitoring of Minimal Residual Disease or Measurable Residual
Disease (MRD) is a very important aspect in the management of patients affected by …

Hypothesis The co-flow step emulsification (CFSE) is very sensitive to the two-phase fluid
interfaces, we conjecture that the CFSE hydrodynamic model depends on several key …

Abstract Chronic Myeloid Leukemia (CML) is marked by the BCR:: ABL1 fusion gene.
Monitoring tyrosine kinase inhibitor (TKI) therapy response is crucial for treatment …

Objectives Chronic myeloid leukemia (CML) is characterized by the Philadelphia
chromosome, leading to the BCR:: ABL1 fusion gene and hyper-proliferation of …